BMI1 and Alzheimer disease: Although additional ENZ (10 μM) treatment could further enhance the AD‐induced BMI1 and SOX2 (Figure 6D) as well as STAT1 and IFIT5 mRNA levels (Figure S6A), it did not reflect on the protein expression from these genes (Figure 6E).